losartan has been researched along with omega-n-methylarginine in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (57.69) | 18.2507 |
2000's | 9 (34.62) | 29.6817 |
2010's | 2 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blantz, RC; De Nicola, L; Gabbai, FB | 1 |
Cachofeiro, V; Nasjletti, A; Sakakibara, T | 1 |
Abe, Y; Aki, Y; Kimura, S; Takenaka, I; Tamaki, T; Yoshida, H | 1 |
Brosnihan, KB; Ferrario, CM; Ganten, D; Kumagai, H; Moriguchi, A | 1 |
Averill, DB; Ferrario, CM; Khosla, MC; Kumagai, H | 1 |
Blantz, RC; Gabbai, FB; Peterson, OW; Thomson, SC; Vallon, V | 1 |
Freeman, BA; Griendling, KK; Harrison, DG; Kurz, S; Münzel, T; Rajagopalan, S; Tarpey, M | 1 |
Cachofeiro, V; Casal, MC; Lahera, V; Maeso, R; Munoz-Garcia, R; Navarro, J; Rodrigo, E; Ruilope, LM | 1 |
Baan, J; Chang, PC; Pfaffendorf, M; van Zwieten, PA; Vermeij, P | 2 |
Cachofeiro, V; Guan, H; Nasjletti, A | 1 |
Boon, NA; Hayes, PC; Jalan, R; Masumori, S; Newby, DE; Webb, DJ | 1 |
Lew, WY; Yasuda, S | 1 |
Baylis, C; Qiu, C | 1 |
Baldassarre, S; Berkenboom, G; Fontaine, D; Fontaine, J; Preumont, N; Unger, P | 1 |
deBlois, D; Hou, Y; Lemay, J | 1 |
Ahlersmann, D; Christoph, A; Drexler, H; Hornig, B; Kohler, C; Landmesser, U; Spiekermann, S; Tatge, H | 1 |
Fetics, B; Hare, JM; Kass, DA; Maughan, WL; Pak, PH; Wittstein, IS | 1 |
Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
Farquharson, C; Sim, JS; Struthers, AD | 1 |
Blantz, RC; Deng, A; Lortie, M; Miracle, CM; Munger, KA; Satriano, J; Suarez, JM; Thomson, SC | 1 |
Shimabukuro, M; Tagawa, T; Ueda, S; Watanabe, S; Yamakawa, K | 1 |
Li, YF; Mayhan, WG; Patel, KP; Wang, W | 1 |
Lee, JH; Ragolia, L; Xia, S | 1 |
Li, YF; Mehta, PP; Patel, KP; Sharma, NM; Zheng, H | 1 |
Jiao, PL; Li, JK; Liu, B; Sun, JC; Tan, X; Wang, WZ; Wang, YK; Wu, ZT | 1 |
4 trial(s) available for losartan and omega-n-methylarginine
Article | Year |
---|---|
Influence of indomethacin and L-NMMA on vascular tone and angiotensin II-induced vasoconstriction in the human forearm.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Forearm; Humans; Indomethacin; Losartan; Male; omega-N-Methylarginine; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System | 1997 |
Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Biological Availability; Coronary Disease; Endothelium, Vascular; Enzyme Activation; Humans; Losartan; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxidative Stress; Radial Artery; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Superoxide Dismutase; Time Factors; Vasodilation | 2001 |
Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man.
Topics: Acetylcholine; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Brachial Artery; Cross-Over Studies; Enzyme Inhibitors; Humans; Losartan; Male; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Renin-Angiotensin System; Sodium Chloride, Dietary; Vasodilator Agents | 2004 |
Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans.
Topics: Acetylcholine; Adult; Anticoagulants; Antihypertensive Agents; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Nonesterified; Heparin; Humans; Lipids; Losartan; Male; omega-N-Methylarginine; Perindopril; Plethysmography; Regional Blood Flow; Renin-Angiotensin System; Vasodilation; Vasodilator Agents | 2005 |
22 other study(ies) available for losartan and omega-n-methylarginine
Article | Year |
---|---|
Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Glomerular Filtration Rate; Glycine; Imidazoles; Kidney Glomerulus; Kidney Tubules; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Saralasin; Tetrazoles | 1992 |
Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Captopril; Hypertension; Imidazoles; Kinins; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1992 |
Effects of angiotensin II on isolated rabbit afferent arterioles.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Arterioles; Aspirin; Biphenyl Compounds; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Lysine; Male; Nitric Oxide; omega-N-Methylarginine; Prostaglandin Antagonists; Prostaglandins; Rabbits; Renal Circulation; Tetrazoles; Vascular Resistance | 1994 |
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Endothelins; Female; Gene Expression; Hemodynamics; Hypertension; Imidazoles; Lisinopril; Losartan; Mice; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Reference Values; Tetrazoles | 1994 |
Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Dipeptides; Heart Rate; Imidazoles; Lisinopril; Losartan; Male; Nitric Oxide; Oligopeptides; omega-N-Methylarginine; Pressoreceptors; Rats; Rats, Inbred SHR; Reflex; Tetrazoles | 1993 |
Interactive control of renal function by alpha 2-adrenergic system and nitric oxide: role of angiotensin II.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Hemodynamics; Imidazoles; Kidney; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Tetrazoles | 1995 |
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
Topics: Acetylcholine; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Arginine; Biphenyl Compounds; Calcimycin; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Hypertension; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides; Tetrazoles | 1996 |
Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Enzyme Inhibitors; Hemodynamics; Hypertension; Imidazoles; Infusions, Intravenous; Kidney; Kinins; Losartan; Male; Meclofenamic Acid; Nitric Oxide; omega-N-Methylarginine; Prostaglandins; Pyridines; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Sodium; Tetrazoles | 1995 |
Contribution of nitric oxide to the acute antihypertensive effect of blockers of AT1 angiotensin receptors in spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Enzyme Inhibitors; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Quinazolines; Quinazolinones; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1997 |
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Forearm; Humans; Liver Cirrhosis; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Renin-Angiotensin System; Sympathetic Nervous System; Sympathomimetics; Vascular Resistance | 1998 |
Effects of angiotensin II and losartan in the forearm of patients with essential hypertension.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Enzyme Inhibitors; Female; Forearm; Humans; Hypertension; Losartan; Male; Methoxamine; Middle Aged; omega-N-Methylarginine; Regional Blood Flow; Vasoconstrictor Agents | 1998 |
Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cells, Cultured; Chelating Agents; Cyclic GMP; Enzyme Inhibitors; Female; Heart Ventricles; Imidazoles; Indoles; Lipopolysaccharides; Losartan; Male; Mitochondria; Muscle Fibers, Skeletal; Myocardial Contraction; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rabbits; Receptors, Angiotensin; Sepsis; Ventricular Function | 1999 |
Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Kidney Glomerulus; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfonamides | 1999 |
Absence of nitrate tolerance after long-term treatment with ramipril: an endothelium-dependent mechanism.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Bradykinin; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Endothelium, Vascular; In Vitro Techniques; Losartan; Male; Nitrates; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Ramipril; Rats; Rats, Wistar; Superoxides; Time Factors; Vasodilator Agents | 1999 |
Evidence that nitric oxide regulates AT1-receptor agonist and antagonist efficacy in rat injured carotid artery.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Carotid Arteries; Carotid Artery Injuries; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstriction | 2000 |
Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Dilated; Compliance; Depression, Chemical; Diastole; Dobutamine; Enalaprilat; Enzyme Inhibitors; Female; Heart; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Ventricular Dysfunction, Left | 2001 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Energy Metabolism; Enzyme Inhibitors; Glomerular Filtration Rate; Kidney Tubules, Proximal; Losartan; Male; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Oxygen Consumption; Rats; Rats, Wistar; Renal Circulation; Sodium | 2005 |
Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Blood Pressure; Feedback, Physiological; Heart Rate; Losartan; Male; Microinjections; Nitric Oxide; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2006 |
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats.
Topics: Aging; Angiotensin II; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Endothelium, Vascular; Imidazoles; Losartan; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; rho-Associated Kinases; Signal Transduction; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |
Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Heart Failure; Hemodynamics; Immunohistochemistry; Kidney; Losartan; Male; Microinjections; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, N-Methyl-D-Aspartate; RNA Interference; RNA, Messenger; Sympathetic Nervous System; Time Factors | 2011 |
The asymmetric dimethylarginine-mediated inhibition of nitric oxide in the rostral ventrolateral medulla contributes to regulation of blood pressure in hypertensive rats.
Topics: Amidohydrolases; Angiotensin II; Animals; Arginine; Blood Pressure; Heart Rate; Kidney; Losartan; Male; Medulla Oblongata; Nitric Oxide; omega-N-Methylarginine; Protein-Arginine N-Methyltransferases; Rats, Inbred WKY; Rats, Sprague-Dawley; Sympathetic Nervous System | 2017 |